**NANOVIRICIDES
      INC.**





Exhibit
      31.1


CERTIFICATIONS








I,
      Eugene Seymour, NanoViricides’ Chief Executive Officer, certify
      that:





1.      I
      have reviewed the annual report on Form 10-KSB of NanoViricides, Inc. (the
      ‘Registrant”) for the year ended June 30, 2007;





2.      Based
      on my knowledge, the annual report does not contain any untrue statement of
      a
      material fact or omit to state a material fact necessary to make the statements
      made, in light of the circumstances under which such statements were made,
      not
      misleading with respect to the period covered by the annual report;





3.      Based
      on my knowledge, the financial statements, and other financial information
      included in the annual report, fairly present in all material respects the
      financial condition, results of operations and cash flows of the Registrant
      as
      of, and for, the periods presented in the annual report;




4.      I
        am responsible for establishing and maintaining disclosure controls and
        procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities
        Exchange Act of 1934) for the small business issuer and have:
  a)
              Designed
                  such disclosure controls and procedures, or caused such disclosure
                  controls and procedures to be designed under my supervision, to
                  ensure
                  that material information relating to the small business issuer,
                  including
                  its consolidated subsidiaries, is made known to me by others within
                  those
                  entities, particularly during the period in which this report is
                  being
                  prepared;
  b)
              Evaluated
                  the effectiveness of the small business issuer’s disclosure controls and
                  procedures and presented in this report my conclusions about the
                  effectiveness of the disclosure controls and procedures, as of
                  the end of
                  the period covered by this report based on such evaluation;
                  and
  c)
              Disclosed
                  in this report any change in the small business issuer's internal
                  control
                  over financial reporting that occurred during the small business
                  issuer's
                  most recent fiscal quarter that has materially affected, or is
                  reasonably
                  likely to materially affect, the small business issuer's internal
                  control
                  over financial reporting; and


5.     The
      Registrant’s other certifying officers and I have disclosed, based on my most
      recent evaluation,  to the Registrant’s auditors and the audit
      committee of the Registrant’s board of directors (or persons performing the
      equivalent function): a) all significant  deficiencies in the design
      or operation of internal controls which could adversely affect the
      Registrant’s  ability  to record,  process,
      summarize and report  financial data and have
      identified  for the Registrant’s auditors any material weaknesses in
      internal controls; and b) any fraud, whether or not material, that involves
      management or other employees  who  have a significant role
      in the Registrant’s internal controls; and





6.     
      I have indicated in the annual report whether or not there were significant
      changes in internal controls or in other factors that could significantly affect
      internal controls subsequent to the date of our most recent evaluation,
      including any corrective actions with regard to significant deficiencies and
      material weaknesses.








Date:
      October 15, 2007





/s/ Eugene SeymourChief
                Executive Officer